4-Phenyl-1,3-benzodioxans
AssigneeBristol-Myers Company
InventorsRonald Leslie Buchanan, Richard Anthony Partyka, Robert Ted Standridge
Life of this patent
Estimating the term…
Loading patent…
AssigneeBristol-Myers Company
InventorsRonald Leslie Buchanan, Richard Anthony Partyka, Robert Ted Standridge
Estimating the term…
Substituted 2-aminomethyl-4-phenyl-1,3-benzodioxans and derivatives thereof have been found to possess valuable anticonvulsant and antiarrhythmia activity in mammals. For example, cis-6-chloro-2-methylaminomethyl-4-phenyl-1,3-benzodioxan hydrochloride possesses potent anticonvulsant activity while cis-2-isopropylaminomethyl-4-phenyl-1,3-benzodioxan hydrochloride has potent antiarrhythmia activity.
The compound having the formula ##STR71## in which X and Y are alike or different and are H, F, Cl, Br, CF.sub.3 or Nitro, Z is a radical having the formula ##STR72## in which R.sup.6 is H, (lower) alkyl or phenyl, R.sup.1 and R.sup.2 are alike or different and each is H, lower alkyl, cycloloweralkyl or when taken together with the nitrogen a heterocyclic ring having the formula ##STR73## and n is an integer of 1 to 4 inclusive;
Dependencies are inferred from the claim text.
Drawings are temporarily unavailable. Open the PDF at USPTO
From the US filing history. Foreign family members aren’t listed.
1,3-Dioxanes; Hydrogenated 1,3-dioxanes: condensed with carbocyclic rings or ring systems
By condensation: friedel-Crafts reactions
Containing hydroxy groups: polycyclic
Having nitro groups and hydroxy groups bound to carbon atoms of the same non-condensed six-membered aromatic ring: having one nitro groups bound…
Term ended 1 Nov 1994 (estimated)
USPTO file history isn’t available for this patent, so only indexed dates are shown.
1. Field of the Invention
This invention relates to novel optionally substituted 2-aminomethyl-4-phenyl-1,3-benzodioxans and derivatives thereof which possess valuable anticonvulsant and antiarrhythmia activity.
2. Description of the Prior Art
5-Chloro-2-hydroxybenzophenone (100.0 g, 0.429 mole) was dissolved with stirring, under anhydrous conditions, in 1 liter of anhydrous THF (tetrahydrofuran) contained in a 5 1. flask. The flask was immersed in an ice-water bath, the solution was stirred vigorously, and 450 ml (0.45 mole) of diborane in THF soln (1M as BH.sub.3) was immediately added from a dropping funnel as rapidly as maintaining control of the reaction would allow; about 4 minutes was required. Foaming occurred and the color of the reaction mixture deepened, then lightened. After addition, the colorless solution was stirred in the cooling bath for 15 minutes and was then poured slowly, cautiously, and with good stirring onto a mixture of cracked ice and 700 ml of 5% HC1 soln.
The insoluble material was extracted out with 3 portions of ether; the combined extracts were washed with dilute NaHCO.sub.3 soln (2 portions), water (1 portion) and saturated brine (1 portion) and dried over anhydrous MgSO.sub.4. Evaporation of the solvents gave an oil which was taken up in hot cyclohexane; the solvent was evaporated and the residue was stripped in vacuum. The oil thus obtained was dissolved i 1200 ml of hot cyclohexane; the solution was filtered, seeded, and allowed to stand at room temperature.
The solid was filtered, washed with cyclohexane, and air-dried. Light cream-colored crystals, mp 93.degree.-95.degree., were obtained. The yield was 64.5 g (62%).